vs

Side-by-side financial comparison of INSMED Inc (INSM) and Palomar Holdings, Inc. (PLMR). Click either name above to swap in a different company.

INSMED Inc is the larger business by last-quarter revenue ($263.8M vs $253.4M, roughly 1.0× Palomar Holdings, Inc.). On growth, INSMED Inc posted the faster year-over-year revenue change (152.6% vs 62.7%). Palomar Holdings, Inc. produced more free cash flow last quarter ($409.0M vs $-264.2M). Over the past eight quarters, INSMED Inc's revenue compounded faster (86.9% CAGR vs 46.2%).

Insmed Inc. is a global biopharmaceutical firm focused on developing and commercializing innovative therapies for patients with serious rare diseases that have high unmet medical needs. Its key offerings target pulmonary and endocrine rare disorders, serving markets across North America, Europe, and Asia Pacific.

Palomar Holdings, Inc. is a specialty insurance holding company that primarily provides property insurance products for catastrophe-exposed residential and commercial assets. It mainly operates across the United States, focusing on core segments including earthquake, flood, and windstorm coverage to meet high-risk property protection demands of customers.

INSM vs PLMR — Head-to-Head

Bigger by revenue
INSM
INSM
1.0× larger
INSM
$263.8M
$253.4M
PLMR
Growing faster (revenue YoY)
INSM
INSM
+90.0% gap
INSM
152.6%
62.7%
PLMR
More free cash flow
PLMR
PLMR
$673.2M more FCF
PLMR
$409.0M
$-264.2M
INSM
Faster 2-yr revenue CAGR
INSM
INSM
Annualised
INSM
86.9%
46.2%
PLMR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
INSM
INSM
PLMR
PLMR
Revenue
$263.8M
$253.4M
Net Profit
$-328.5M
Gross Margin
83.2%
Operating Margin
-121.2%
28.7%
Net Margin
-124.5%
Revenue YoY
152.6%
62.7%
Net Profit YoY
-39.5%
EPS (diluted)
$-1.55
$2.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INSM
INSM
PLMR
PLMR
Q4 25
$263.8M
$253.4M
Q3 25
$142.3M
$244.7M
Q2 25
$107.4M
$203.3M
Q1 25
$92.8M
$174.6M
Q4 24
$104.4M
$155.8M
Q3 24
$93.4M
$148.5M
Q2 24
$90.3M
$131.1M
Q1 24
$75.5M
$118.5M
Net Profit
INSM
INSM
PLMR
PLMR
Q4 25
$-328.5M
Q3 25
$-370.0M
$51.5M
Q2 25
$-321.7M
$46.5M
Q1 25
$-256.6M
$42.9M
Q4 24
$-235.5M
Q3 24
$-220.5M
$30.5M
Q2 24
$-300.6M
$25.7M
Q1 24
$-157.1M
$26.4M
Gross Margin
INSM
INSM
PLMR
PLMR
Q4 25
83.2%
Q3 25
79.4%
Q2 25
73.9%
Q1 25
77.1%
Q4 24
75.0%
Q3 24
77.3%
Q2 24
76.8%
Q1 24
76.9%
Operating Margin
INSM
INSM
PLMR
PLMR
Q4 25
-121.2%
28.7%
Q3 25
-257.1%
27.4%
Q2 25
-291.3%
29.5%
Q1 25
-267.3%
30.8%
Q4 24
-220.6%
28.9%
Q3 24
-228.4%
25.9%
Q2 24
-319.8%
25.5%
Q1 24
-192.7%
29.0%
Net Margin
INSM
INSM
PLMR
PLMR
Q4 25
-124.5%
Q3 25
-260.0%
21.0%
Q2 25
-299.5%
22.9%
Q1 25
-276.4%
24.6%
Q4 24
-225.5%
Q3 24
-236.0%
20.5%
Q2 24
-332.8%
19.6%
Q1 24
-208.1%
22.3%
EPS (diluted)
INSM
INSM
PLMR
PLMR
Q4 25
$-1.55
$2.05
Q3 25
$-1.75
$1.87
Q2 25
$-1.70
$1.68
Q1 25
$-1.42
$1.57
Q4 24
$-1.30
$1.29
Q3 24
$-1.27
$1.15
Q2 24
$-1.94
$1.00
Q1 24
$-1.06
$1.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INSM
INSM
PLMR
PLMR
Cash + ST InvestmentsLiquidity on hand
$1.4B
$106.9M
Total DebtLower is stronger
$546.8M
Stockholders' EquityBook value
$739.0M
$942.7M
Total Assets
$2.3B
$3.1B
Debt / EquityLower = less leverage
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INSM
INSM
PLMR
PLMR
Q4 25
$1.4B
$106.9M
Q3 25
$1.7B
$111.7M
Q2 25
$1.9B
$81.3M
Q1 25
$1.2B
$119.3M
Q4 24
$1.4B
$80.4M
Q3 24
$1.5B
$86.5M
Q2 24
$1.2B
$47.8M
Q1 24
$595.7M
$61.4M
Total Debt
INSM
INSM
PLMR
PLMR
Q4 25
$546.8M
Q3 25
$546.8M
Q2 25
$546.8M
Q1 25
$1.1B
Q4 24
$1.1B
Q3 24
$971.8M
Q2 24
$1.2B
Q1 24
$1.2B
Stockholders' Equity
INSM
INSM
PLMR
PLMR
Q4 25
$739.0M
$942.7M
Q3 25
$945.6M
$878.1M
Q2 25
$1.2B
$847.2M
Q1 25
$99.2M
$790.4M
Q4 24
$285.4M
$729.0M
Q3 24
$483.4M
$703.3M
Q2 24
$38.8M
$532.6M
Q1 24
$-464.8M
$501.7M
Total Assets
INSM
INSM
PLMR
PLMR
Q4 25
$2.3B
$3.1B
Q3 25
$2.4B
$2.9B
Q2 25
$2.5B
$2.8B
Q1 25
$1.8B
$2.4B
Q4 24
$2.0B
$2.3B
Q3 24
$2.1B
$2.3B
Q2 24
$1.8B
$2.0B
Q1 24
$1.2B
$1.9B
Debt / Equity
INSM
INSM
PLMR
PLMR
Q4 25
0.74×
Q3 25
0.58×
Q2 25
0.44×
Q1 25
11.31×
Q4 24
3.93×
Q3 24
2.01×
Q2 24
30.66×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INSM
INSM
PLMR
PLMR
Operating Cash FlowLast quarter
$-247.6M
$409.1M
Free Cash FlowOCF − Capex
$-264.2M
$409.0M
FCF MarginFCF / Revenue
-100.1%
161.4%
Capex IntensityCapex / Revenue
6.3%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-967.6M
$700.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INSM
INSM
PLMR
PLMR
Q4 25
$-247.6M
$409.1M
Q3 25
$-219.8M
$83.6M
Q2 25
$-205.6M
$120.9M
Q1 25
$-262.1M
$87.2M
Q4 24
$-196.0M
$261.2M
Q3 24
$-180.9M
$100.3M
Q2 24
$-123.0M
$55.1M
Q1 24
$-184.0M
$33.1M
Free Cash Flow
INSM
INSM
PLMR
PLMR
Q4 25
$-264.2M
$409.0M
Q3 25
$-222.2M
$83.6M
Q2 25
$-209.1M
$120.8M
Q1 25
$-272.2M
$87.1M
Q4 24
$-202.8M
$260.9M
Q3 24
$-184.6M
$100.1M
Q2 24
$-129.7M
Q1 24
$-188.7M
FCF Margin
INSM
INSM
PLMR
PLMR
Q4 25
-100.1%
161.4%
Q3 25
-156.1%
34.2%
Q2 25
-194.6%
59.4%
Q1 25
-293.2%
49.9%
Q4 24
-194.1%
167.5%
Q3 24
-197.6%
67.4%
Q2 24
-143.6%
Q1 24
-250.0%
Capex Intensity
INSM
INSM
PLMR
PLMR
Q4 25
6.3%
0.1%
Q3 25
1.7%
0.0%
Q2 25
3.2%
0.0%
Q1 25
10.8%
0.0%
Q4 24
6.5%
0.2%
Q3 24
3.9%
0.1%
Q2 24
7.5%
0.0%
Q1 24
6.2%
0.0%
Cash Conversion
INSM
INSM
PLMR
PLMR
Q4 25
Q3 25
1.63×
Q2 25
2.60×
Q1 25
2.03×
Q4 24
Q3 24
3.29×
Q2 24
2.14×
Q1 24
1.26×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons